Jay W.
Pettegrew, M.D.
Geddes JW, Panchalingam K, and
PETTEGREW JW. Elevated phosphocholine and phosphatidylcholine
following rat entorhinal cortex lesions. Neurobiological Aging,
18(3): 305-308, 1997.
Keshavan MS, Schooler NR, Sweeney JA,
Haas, GL, and PETTEGREW JW. Research and treatment strategies
in first episode psychoses: the pittsburgh experience. British
Journal of Psychiatry, 172(33): 60-65, 1998.
Keshavan MS, Stanley JA, and PETTEGREW
JW. Magnetic resonance spectroscopy in schizophrenia:
methodological issues and findings, part II. Biological Psychiatry,
48: 369-380, 2000.
Klunk WE, Panchalingam K, McClure RJ,
Stanley JA, and PETTEGREW JW. Metabolic alterations in
post-mortem alzheimer’s disease brain are exaggerated by apo-e4.
Neurobiological Aging, 19(6): 511-515, 1998.
Klunk WE, Xu C-J, McClure RJ, and
PETTEGREW JW. Aggregation of b-amyloid peptide is promoted by
membrane phospholipid metabolites elevated in alzheimer’s disease. Journal of Neurochemistry, 69: 266-272, 1997.
Klunk WE, Xu CJ,
Panchalingam K, McClure RJ and PETTEGREW JW. Quantitative
1h and 31p mrs of pca extracts of postmortem
alzheimer’s disease brain. Neurobiological Aging, 17: 349-357,
1996.
Mandal PK, PETTEGREW JW, McKeag DW, Mandal R.
Alzheimer's disease: halothane induces
Abeta peptide to oligomeric form--solution NMR studies. Neurochem
Res. 2006 Jul;31(7):883-90. Epub 2006 Jun 29
Mandal PK, PETTEGREW JW, Masliah E, Hamilton RL, Mandal R.
Interaction between Abeta peptide and alpha synuclein: molecular
mechanisms in overlapping pathology of Alzheimer's and Parkinson's in
dementia with Lewy body disease. Neurochem Res. 2006 Sep;31(9):1153-62.
Epub 2006 Sep 1
Mandal
PK, McClure RJ, and PETTEGREW JW. Interactions of aβ(1-40)
with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studies.
Neurochemical Research,
29: 2261-2267, 2004.
Mandal PK and PETTEGREW JW. Alzheimer’s disease: soluble oligomeric aβ(1-40) peptide in membrane mimic environment from
solution nmr and cd studies” Neurochemical Research, 29: 2255-2260, 2004.
Mason RP, Trumbore MW, and PETTEGREW
JW. Molecular membrane interactions of a phospholipid
metabolite. implications for alzheimer’s disease pathophysiology.
Annals of the New York Academy
of Sciences, 96: 368-373, 1996.
Mason RM, Trumbore M. and
PETTEGREW JW. Membrane interactions of a phosphomonoester
elevated early in alzheimer’s disease. Neurobiological Aging, 16: 531-539,
1995.
McClure RJ, Keshavan MS, and PETTEGREW
JW. Chemical and physiologic brain imaging in schizophrenia.
Psychiatric Clinics of North America, 21(3): 93-122, 1998.
PETTEGREW JW, Keshavan, MS,
Stanley JA, McClure RJ, Johnson CR and Panchalingam K. Magnetic
resonance spectroscopy in the assessment of phospholipid metabolism in
schizophrenia and other psychiatric disorders. In: Phospholipid Spectrum
Disorder in Psychiatry (eds. Peet M, Glen I and Horrobin DF), Marious-Carnford, UK, pp. 239-255, 2003.
PETTEGREW
JW, Klunk WE, Panchalingam K, Kanfer JN and McClure RJ. Clinical
and neurochemical effects of acetyl-l-carnitine in alzheimer's
disease. Neurobiological Aging, 16: 1-4, 1995.
PETTEGREW JW, Klunk WE,
Panchalingam K, McClure RJ and Stanley JA. Molecular insights into neurodevelopmental
and neurodegenerative diseases. Brain Research Bulletin, 53: 455-469, 2000.
PETTEGREW JW, Levine J, Gershon S,
Stanley JA, Servan, Schreiber D, Panchalingam K and McClure RJ.
31P-mrs study of acetyl-l-carnitine treatment in geriatric
depression: preliminary results. Bipolar Disorders, 4: 61-66, 2002.
PETTEGREW JW, Levine J, and
McClure RJ. Acetyl-l-carnitine
physical, chemical, metabolic and therapeutic properties: relevance
for its mode of action in alzheimer’s disease and geriatric
depression. Molecular Psychiatry,
5: 616-632, 2000.
PETTEGREW JW, McClure RJ, Keshavan
MS, Minshew NJ, Panchalingam K, and Klunk WE. 31P
magnetic resonance spectroscopy studies of developing brain. In:
Neurodevelopment & Adult Psychopathology, Keshavan MS and Murray
RM (eds.), Cambridge University Press, 6: 71-92, 1997.
PETTEGREW JW, Panchalingam K,
Hamilton RL and McClure RJ. Brain membrane phospholipid alterations
in alzheimer's disease. Neurochemical Research, 26: 771-782, 2001.
PETTEGREW JW, Panchalingam K,
Levine J, McClure RJ, Gershon S, and Yao J. K. Chronic myo-inositol
increases rat brain phosphatidylethanolamine plasmalogen.
Biological Psychiatry,
49: 444-453, 2001.
PETTEGREW JW, Panchalingam K,
McClure RJ and Levine J. Brain metabolic effects of acute nicotine.
Neurochemical Research, 26: 181-185, 2001.
Stanley JA, Kipp H,
Greisenegger E, MacMaster FP, Panchalingam K, PETTEGREW JW,
Keshavan MS, Bukstein OG. Regionally specific alterations in
membrane phospholipids in children with ADHD: An in vivo 31P
spectroscopy study. Psychiatry Res. 2006 Dec 1;148(2-3):217-21.
Epub 2006 Nov 7
Stanley JA and PETTEGREW JW. Postprocessing method to segregate and quantify the broad components
under-lying the phosphodiester spectral region of in vivo
31p brain spectra. Magnetic Resonance in Medicine, 45: 390-396,
2001.
Stanley JA and PETTEGREW JW. Post-processing method to segregate and quantify the broad components
underlying the phosphodiester spectral region of in vivo
31p brain spectra. Magnetic Resonance in Medicine, 45: 390-396, 2001.
Stanley JA, PETTEGREW JW, and
Keshavan MS. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings, part
I.
Biological Psychiatry,
48: 357-368, 2000.
Stanley JA, PETTEGREW JW,
Panchalingam K, McClure RJ, Harenski K, Montrose DM and Keshavan MS.
Focal and global alterations of membrane phospholipid metabolism in
offspring subjects of schizophrenia parents: an in vivo 31p
mrs study. Schizophrenia Research, 49: 195, 2001.
Xu CJ, Kanfer JN, Klunk WE,
Xiong Q, McClure RJ and PETTEGREW JW. Effect of phosphomonoesters,
phosphodiesters, and phosphocreatine on glutamate uptake by synaptic
vesicles. Molecular Neurochemical Neuropathology, 32: 89-99, 1997.
Xu CJ, Klunk WE, Kanfer
JN, Xiong Q, Miller G & PETTEGREW JW. Phosphocreatine-dependent
glutamate uptake by synaptic vesicles: a comparison with atp-dependent
glutamate uptake. Journal of Biological Chemistry, 271: 13435-13440, June 1996.
Go to Top